SEC Form 4 · accession 0001735276-19-000016
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret A Hamburg
Director
Period of report
Jan 10, 2019
Accepted (ET)
Jan 11, 2019 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $89.16 | Jan 10, 2019 | A | 18,000 | A | — | Jan 10, 2029 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.